← Open Payments lookup

SCOTT HEILMANN: Open Payments

NPI 1164875894 · PANAMA CITY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,640 in 69 payments from 25 companies in 2025. Trend: 2023 $2,622 · 2024 $1,873 · 2025 $1,640

Food & beverage: $1,640
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP12$242
Novo Nordisk Inc4$162
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$140
GlaxoSmithKline, LLC.8$130
Otsuka America Pharmaceutical, Inc.1$116
Bayer Healthcare Pharmaceuticals Inc.4$100
ABBVIE INC.4$75
PFIZER INC.4$74
Novartis Pharmaceuticals Corporation3$70
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$60

Products named: AIRSUPRA, CAPLYTA, Ozempic, TRELEGY ELLIPTA, REXULTI, Kerendia, LEQVIO, XIFAXAN.

Industry payments across FL — which companies pay providers there.